Merck, through a subsidiary, will acquire Verona Pharma for a total transaction value of approximately $10 billion.

British American Tobacco ( NYSE: BTI) was noted to have a strong balance sheet and rich cash returns, while room for improvement with margins is seen. In terms of valuation, British American Tobacco ( ...

The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...

According to the Financial Times, MSD – known as Merck & Co in the US and Canada – is in the final stages of a $10 billion ...

A company expected to fare well during this time is Eli Lilly, with revenue forecast to improve by 165% in 2030. This will largely be driven by the company’s glucagon like peptide-1 receptor agonist ...

The $8 billion deal, which remains stuck in regulatory limbo, is poised to trigger its second 90-day extension next week.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its second-quarter 2025 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET ...

Discover why MSD may face challenges as a hedge against a weaker dollar. Explore its premium valuation, low spreads, and potential downside.